Latest Business Development News

Starpharma reports a 165% rise in FY25 customer receipts, advances its clinical-stage DEP® assets, and secures new distribution deals in Asia and Saudi Arabia.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

RemSense Technologies closed FY2025 with a positive EBITDA and expanding virtualplant platform usage among major clients, setting the stage for significant growth in FY2026. The company’s strategic hires and new contracts highlight its rising footprint in industrial digital transformation.

Empire Resources has completed a significant 21-hole reverse circulation drilling campaign at its Yuinmery Project, targeting copper-gold mineralisation across multiple prospects. Assay results are pending, with the company poised to define resource potential amid ongoing exploration.

Stelar Metals has been granted a new exploration licence in South Australia targeting titanium-rich heavy mineral sands, while also uncovering promising tin potential at its New South Wales Trident Project.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

ACDC Metals has reported strong scoping study results for its Goschen Central heavy mineral sands and rare earth project, highlighting a promising 14-year mine life and a strategic retention licence application to support ongoing development.

Vitrafy Life Sciences reported robust progress in Q4 FY2025, advancing its cryopreservation technology and commercial partnerships while preparing for a pivotal product launch in FY2026.

Patrys Limited has completed a modest capital raise and restructured its leadership as it advances its deoxymab antibody program, with a larger entitlement offer announced to fund clinical development and business growth.

Skylark Minerals reports solid progress in its Simon Copper and Perseverance Projects with ongoing fieldwork analysis, while maintaining a strong cash position and advancing gold asset acquisitions.

Supply Network Limited reported solid FY2025 results with 15% revenue growth and expanded its branch footprint, setting sights on further growth despite upcoming operational changes.